Relugolix: Phase 1 Study in Healthy Males.

Trial Profile

Relugolix: Phase 1 Study in Healthy Males.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2015

At a glance

  • Drugs Relugolix (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Takeda Oncology
  • Most Recent Events

    • 03 Nov 2015 New trial record
    • 26 Oct 2015 Results published online in The Journal of clinical endocrinology and metabolism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top